The characteristics and prognostic role of acute abdominal on-admission pain in acute pancreatitis: A prospective cohort analysis of 1432 cases.


Journal

European journal of pain (London, England)
ISSN: 1532-2149
Titre abrégé: Eur J Pain
Pays: England
ID NLM: 9801774

Informations de publication

Date de publication:
03 2022
Historique:
received: 20 04 2021
accepted: 17 10 2021
pubmed: 11 11 2021
medline: 5 3 2022
entrez: 10 11 2021
Statut: ppublish

Résumé

Pain is the most common symptom in acute pancreatitis (AP) and is among the diagnostic criteria. Therefore, we aimed to characterize acute abdominal pain in AP. The Hungarian Pancreatic Study Group prospectively collected multicentre clinical data on 1435 adult AP patients between 2012 and 2017. Pain was characterized by its intensity (mild or intense), duration prior to admission (hours), localization (nine regions of the abdomen) and type (sharp, dull or cramping). 97.3% of patients (n = 1394) had pain on admission. Of the initial population with acute abdominal pain, 727 patients answered questions about pain intensity, 1148 about pain type, 1134 about pain localization and 1202 about pain duration. Pain was mostly intense (70%, n = 511/727), characterized by cramping (61%, n = 705/1148), mostly starting less than 24 h prior to admission (56.7%, n = 682/1202). Interestingly, 50.9% of the patients (n = 577/1134) had atypical pain, which means pain other than epigastric or belt-like upper abdominal pain. We observed a higher proportion of peripancreatic fluid collection (19.5% vs. 11.0%; p = 0.009) and oedematous pancreas (8.4% vs. 3.1%; p = 0.016) with intense pain. Sharp pain was associated with AP severity (OR = 2.481 95% CI: 1.550-3.969) and increased mortality (OR = 2.263, 95% CI: 1.199-4.059) compared to other types. Longstanding pain (>72 h) on admission was not associated with outcomes. Pain characteristics showed little association with the patient's baseline characteristics. A comprehensive patient interview should include questions about pain characteristics, including pain type. Patients with sharp and intense pain might need special monitoring and tailored pain management. Acute abdominal pain is the leading presenting symptom in acute pancreatitis; however, we currently lack specific guidelines for pain assessment and management. In our cohort analysis, intense and sharp pain on admission was associated with higher odds for severe AP and several systemic and local complications. Therefore, a comprehensive patient interview should include questions about pain characteristics and patients with intense and sharp pain might need closer monitoring.

Identifiants

pubmed: 34758174
doi: 10.1002/ejp.1885
pmc: PMC9299627
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

610-623

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 The Authors. European Journal of Pain published by John Wiley & Sons Ltd on behalf of European Pain Federation - EFIC ®.

Références

United European Gastroenterol J. 2020 Apr;8(3):246-248
pubmed: 32310740
Pancreas. 2019 Feb;48(2):176-181
pubmed: 30629020
Pancreatology. 2017 Mar - Apr;17(2):155-165
pubmed: 28159463
Am J Gastroenterol. 2019 Aug;114(8):1322-1342
pubmed: 31205135
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1567-1575.e2
pubmed: 31712075
Eur J Pain. 2019 Oct;23(9):1701-1711
pubmed: 31241807
Cochrane Database Syst Rev. 2013 Jul 26;(7):CD009179
pubmed: 23888429
Pancreatology. 2017 Sep - Oct;17(5):706-719
pubmed: 28733149
Ann R Coll Surg Engl. 2019 Sep;101(7):487-494
pubmed: 31362520
Pancreas. 2017 Apr;46(4):504-509
pubmed: 28196012
EBioMedicine. 2019 Aug;46:431-443
pubmed: 31401195
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
ANZ J Surg. 2017 Sep;87(9):700-703
pubmed: 25924928
Pharmaceuticals (Basel). 2010 Mar 10;3(3):558-571
pubmed: 27713268
J Pain. 2007 Feb;8(2):118-26
pubmed: 16949878
J Pain. 2009 May;10(5):447-85
pubmed: 19411059
Support Care Cancer. 2020 Feb;28(2):589-598
pubmed: 31098795
J Pain Res. 2016 Nov 16;9:1057-1066
pubmed: 27895511
Pancreatology. 2012 Mar-Apr;12(2):104-12
pubmed: 22487519
Gut. 2013 Jan;62(1):102-11
pubmed: 23100216
Eur J Pain. 2022 Mar;26(3):610-623
pubmed: 34758174
Gastroenterol Rep (Oxf). 2018 May;6(2):127-131
pubmed: 29780601
Pain. 2005 Jan;113(1-2):9-19
pubmed: 15621359
Clin J Pain. 2018 Jan;34(1):30-36
pubmed: 28481836
Pain. 1996 May-Jun;65(2-3):123-67
pubmed: 8826503
J Pain Res. 2018 Sep 11;11:1803-1809
pubmed: 30254482
Am J Gastroenterol. 2019 May;114(5):813-821
pubmed: 31008736
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Front Physiol. 2019 Apr 02;9:1776
pubmed: 31001148
Front Physiol. 2019 Sep 20;10:1202
pubmed: 31620021
J Pain. 2016 Feb;17(2):131-57
pubmed: 26827847
Pancreatology. 2017 Sep - Oct;17(5):720-731
pubmed: 28734722
J Pain. 2012 Jan;13(1):58-63
pubmed: 22172451
JOP. 2013 Mar 10;14(2):171-5
pubmed: 23474564
Orv Hetil. 2015 Feb 15;156(7):244-61
pubmed: 25661970
J Pain Res. 2019 May 27;12:1721-1732
pubmed: 31213884
Int J Surg. 2018 Jun;54(Pt A):76-81
pubmed: 29684670
PLoS One. 2016 Oct 31;11(10):e0165309
pubmed: 27798670
Clin Res Hepatol Gastroenterol. 2020 Jan-Jun;44S:100002
pubmed: 33602483
Pancreas. 2019 Feb;48(2):169-175
pubmed: 30629021
Ann Intern Med. 2016 Apr 19;164(8):542-52
pubmed: 26928912
World J Gastroenterol. 2017 May 21;23(19):3538-3545
pubmed: 28596690
Dig Liver Dis. 2017 Jun;49(6):585-594
pubmed: 28262458
Pancreatology. 2013 May-Jun;13(3):201-6
pubmed: 23719588
Eur J Gastroenterol Hepatol. 2017 Nov;29(11):1269-1275
pubmed: 28857897
Pancreas. 2013 May;42(4):647-54
pubmed: 23303202
Nat Rev Gastroenterol Hepatol. 2015 Nov;12(11):649-59
pubmed: 26460352
Pancreatology. 2013 Jul-Aug;13(4 Suppl 2):e1-15
pubmed: 24054878
Pancreatology. 2020 Jun;20(4):608-616
pubmed: 32402696
Gut. 2018 Apr;67(4):600-602
pubmed: 28642332
Dig Liver Dis. 2007 Sep;39(9):838-46
pubmed: 17602904
Pain. 2016 Sep;157(9):1851-1871
pubmed: 27152687

Auteurs

Mária Földi (M)

Centre for Translational Medicine, Department of Medicine, University of Szeged, Szeged, Hungary.
Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
Doctoral School of Clinical Medicine, University of Szeged, Szeged, Hungary.

Noémi Gede (N)

Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.

Szabolcs Kiss (S)

Centre for Translational Medicine, Department of Medicine, University of Szeged, Szeged, Hungary.
Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
Doctoral School of Clinical Medicine, University of Szeged, Szeged, Hungary.

Áron Vincze (Á)

Division of Gastroenterology, First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.

Judit Bajor (J)

Division of Gastroenterology, First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.

Imre Szabó (I)

Division of Gastroenterology, First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.

Zoltán Szepes (Z)

Department of Medicine, University of Szeged, Szeged, Hungary.

Ferenc Izbéki (F)

Szent György University Teaching Hospital of Fejér County, Székesfehérvár, Hungary.

Judit Gervain (J)

Szent György University Teaching Hospital of Fejér County, Székesfehérvár, Hungary.

József Hamvas (J)

Péterfy Hospital, Budapest, Hungary.

Zsuzsanna Vitális (Z)

Division of Gastroenterology, Department of Internal Medicine, University of Debrecen, Debrecen, Hungary.

Eszter Fehér (E)

Division of Gastroenterology, Department of Internal Medicine, University of Debrecen, Debrecen, Hungary.

Stefan Crai (S)

Pándy Kálmán Hospital of Békés County, Gyula, Hungary.

Ville Sallinen (V)

Department of Transplantation and Liver Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Elena Ramirez-Maldonado (E)

General Surgery, Consorci Sanitari del Garraf, Saint Pere de Ribes, Spain.

Ágnes Meczker (Á)

Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.

Péter Varjú (P)

Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.

Goran Poropat (G)

Clinical Hospital Center Rijeka, Rijeka, Croatia.

Davor Stimac (D)

Clinical Hospital Center Rijeka, Rijeka, Croatia.

Nándor Faluhelyi (N)

Department of Medical Imaging, Medical School, University of Pécs, Pécs, Hungary.

Attila Miseta (A)

Department of Laboratory Medicine, Medical School, University of Pécs, Pécs, Hungary.

Tamás Nagy (T)

Department of Laboratory Medicine, Medical School, University of Pécs, Pécs, Hungary.

Zsolt Márton (Z)

First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.

András Vereczkei (A)

Department of Surgery, Medical School, University of Pécs, Pécs, Hungary.

Péter Jenő Hegyi (P)

Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
Center for Translational Medicine, Semmelweis University, Budapest, Hungary.

Andrea Párniczky (A)

Centre for Translational Medicine, Department of Medicine, University of Szeged, Szeged, Hungary.
Center for Translational Medicine, Semmelweis University, Budapest, Hungary.
Heim Pál National Pediatric Institute, Budapest, Hungary.

Péter Hegyi (P)

Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
Center for Translational Medicine, Semmelweis University, Budapest, Hungary.
Division of Pancreatic Diseases, Heart and Vascular Center, Semmelweis University, Budapest, Hungary.

Andrea Szentesi (A)

Centre for Translational Medicine, Department of Medicine, University of Szeged, Szeged, Hungary.
Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
Center for Translational Medicine, Semmelweis University, Budapest, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH